Carma Fund Overview
CARMA FUND I is an early-stage investment fund established in June 2022, managing €56 million to support the translation of Life Science and Healthcare assets. Based in Munich and Frankfurt am Main, the fund focuses on Med-Tech, Health-Tech, and Bio-Tech sectors, offering flexible investment modes and maintaining close relationships with leading technology transfer offices and industry partners.
Is Carma Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Carma Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
Carma Fund
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
Product type
- Software
- Hardware
- Software-enabled hardware
- Drugs / Pharma
- Other
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
€100,000 - €1,500,000
How to approach funds like Carma Fund
When approaching CARMA FUND I, emphasize how your early-stage Life Science or Healthcare innovation aligns with their focus on therapeutics, diagnostics, MedTech, and digital health. Highlight your project's potential for significant patient benefit and its readiness for translation from research to market. Demonstrating a clear path to commercialization and a strong connection to leading technology transfer offices will resonate with their investment strategy.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
